Prelude Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-4,532
| Closed | -$421K | – | 2176 |
|
2021
Q4 | $421K | Buy |
+4,532
| New | +$421K | 0.01% | 871 |
|
2021
Q1 | – | Sell |
-3,403
| Closed | -$261K | – | 1499 |
|
2020
Q4 | $261K | Buy |
3,403
+1,489
| +78% | +$114K | 0.01% | 566 |
|
2020
Q3 | $143K | Buy |
1,914
+157
| +9% | +$11.7K | 0.01% | 583 |
|
2020
Q2 | $111K | Buy |
+1,757
| New | +$111K | 0.01% | 632 |
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$57K | – | 1856 |
|
2017
Q2 | $57K | Sell |
3,400
-6,140
| -64% | -$103K | 0.01% | 874 |
|
2017
Q1 | $139K | Buy |
9,540
+6,170
| +183% | +$89.9K | 0.01% | 639 |
|
2016
Q4 | $48K | Buy |
3,370
+720
| +27% | +$10.3K | 0.01% | 1018 |
|
2016
Q3 | $46K | Sell |
2,650
-1,980
| -43% | -$34.4K | ﹤0.01% | 1002 |
|
2016
Q2 | $79K | Buy |
4,630
+3,070
| +197% | +$52.4K | 0.01% | 800 |
|
2016
Q1 | $31K | Sell |
1,560
-2,120
| -58% | -$42.1K | ﹤0.01% | 975 |
|
2015
Q4 | $70K | Buy |
+3,680
| New | +$70K | 0.01% | 884 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 2163 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 2106 |
|